Kai Januschowski1,2,3, Peter Szurman4,5, Koen Willekens6, Michael J Bojdys7, Karl Boden4. 1. Augenklinik Sulzbach, Knappschaftsklinikum Saar GmbH, An der Klinik 10, 66280, Sulzbach/Saar, Deutschland. kai.januschowski@kksaar.de. 2. Department für Augenheilkunde, Universitätsaugenklinik Tübingen, Schleichstr. 12, 72076, Tübingen, Deutschland. kai.januschowski@kksaar.de. 3. Klaus Heimann Eye Research Institute, An der Klinik 10, 66280, Sulzbach/Saar, Deutschland. kai.januschowski@kksaar.de. 4. Augenklinik Sulzbach, Knappschaftsklinikum Saar GmbH, An der Klinik 10, 66280, Sulzbach/Saar, Deutschland. 5. Klaus Heimann Eye Research Institute, An der Klinik 10, 66280, Sulzbach/Saar, Deutschland. 6. Department für Augenheilkunde, Universitätsaugenklinikum Löwen, Herestraat 49, 3000, Löwen, Belgien. 7. Department für Chemie, Humboldt-Universität zu Berlin, Brook-Taylor-Str. 2, 12489, Berlin, Deutschland.
Abstract
BACKGROUND: Acute toxicity of perfluorocarbon liquids (PFCL) is a relevant problem in retinal surgery due to impurities in the medicinal product. OBJECTIVE: This article gives an overview of the current problems, possible explanations, interactions with other medicinal products and approaches to improved patient safety. RESULTS: Toxicity is caused by impurities in the raw material but can also be caused by interactions with other medicinal products or drugs. The current test procedures do not ideally represent the ophthalmological application but there are promising activities to set the course for the future. CONCLUSION: The use of PFCL in retinal surgery is generally considered safe. Users should pay attention to the quality of medicinal products.
BACKGROUND: Acute toxicity of perfluorocarbon liquids (PFCL) is a relevant problem in retinal surgery due to impurities in the medicinal product. OBJECTIVE: This article gives an overview of the current problems, possible explanations, interactions with other medicinal products and approaches to improved patient safety. RESULTS:Toxicity is caused by impurities in the raw material but can also be caused by interactions with other medicinal products or drugs. The current test procedures do not ideally represent the ophthalmological application but there are promising activities to set the course for the future. CONCLUSION: The use of PFCL in retinal surgery is generally considered safe. Users should pay attention to the quality of medicinal products.
Entities:
Keywords:
Impurity; Medicinal products; Patient safety; Perfluorocarbon liquids; Retinal surgery
Authors: Bernd Kirchhof; David Wong; Jan Van Meurs; Ralf D Hilgers; Marc Macek; Noemi Lois; Norbert F Schrage Journal: Am J Ophthalmol Date: 2002-01 Impact factor: 5.258
Authors: Marc A Veckeneer; Simone de Voogd; Eric W Lindstedt; Dirk-Henning Menz; Jan C van Meurs Journal: Graefes Arch Clin Exp Ophthalmol Date: 2008-02-26 Impact factor: 3.117
Authors: Kai Januschowski; Cristina Irigoyen; J Carlos Pastor; Girish K Srivastava; Mario R Romano; Heinrich Heimann; Peter Stalmans; Karel Van Keer; Karl Boden; Peter Szurman; Martin S Spitzer Journal: Ophthalmologica Date: 2018-07-12 Impact factor: 3.250
Authors: Mario R Romano; Jose L Vallejo-Garcia; Francesco Parmeggiani; Vito Romano; Romano Vito; Paolo Vinciguerra Journal: Curr Eye Res Date: 2012-05-11 Impact factor: 2.424
Authors: Maximilian Schultheiss; Sven Schnichels; Thoralf Hermann; Jose Hurst; Marita Feldkaemper; Blanca Arango-Gonzalez; Marius Ueffing; Karl U Bartz-Schmidt; Guenther Zeck; Martin S Spitzer Journal: PLoS One Date: 2016-02-05 Impact factor: 3.240